Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $40.76 Million |
|---|---|
| Enterprise Value | $59.77 Million |
| Earnings per Share | $- |
| Beta | 0.85 |
| Outstanding Shares | - |
| P/E Ratio | -1.03 |
|---|---|
| PEG | -7.06 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.69 |
| Enterprise Value to EBIT | -18.57 |
| Enterprise Value to Net Income | -235 |
| Total Debt to Enterprise | 0.61 |
| Debt to Equity | 1.34 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Headquartered in Nantes, France, OSE Immunotherapeutics S.A. is a biotechnology company dedicated to pioneering immunotherapies. Its research and development efforts are concentrated on modulating immune responses, specifically in the do...